NewsBenzingaIonis Pharmaceuticals And Partner Roche Said Prespecified Interim Results From Phase 3 IMAgINATION Study Of Sefaxersen For Primary IgA Nephropathy Met Its Primary Endpoint Of Statistically Significant And Clinically Meaningful Improvements In... Ionis Pharmaceuticals And Partner Roche Said Prespecified Interim Results From Phase 3 IMAgINATION Study Of Sefaxersen For Primary IgA Nephropathy Met Its Primary Endpoint Of Statistically Significant And Clinically Meaningful Improvements In... Benzinga 2026.09.23 08:51 (GMT+0) Open on Benzinga Other news Disney: Skydance Is A Bullish Catalyst (NYSE:DIS) Bill Gates Pushes for AI Safety Rules Along the Lines of Planes, Cars and Medicine: ‘We’re Not Where We Need to Be Yet’ 3 Things I Think I Think Solana ETFs End a 14-Week Buying Streak With Their Largest Weekly Exit SpaceX Becomes a Mobile Carrier in 2027? Crypto Punters Weigh Odds as Elon Musk Calls Spectrum Deal the ‘Last Critical Piece’ of the Puzzle Trader mk4's NEAR long position now has unrealized profits exceeding $20 million
Bill Gates Pushes for AI Safety Rules Along the Lines of Planes, Cars and Medicine: ‘We’re Not Where We Need to Be Yet’
SpaceX Becomes a Mobile Carrier in 2027? Crypto Punters Weigh Odds as Elon Musk Calls Spectrum Deal the ‘Last Critical Piece’ of the Puzzle
